Keywords of "The novel NF-kB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism."

Label
  • Keywords of "The novel NF-kB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism." (literal)
  • Parole chiave di "The novel NF-kB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism." (literal)
Insieme di parole chiave di
Ha membro

Incoming links:


Insieme di parole chiave
Membro di
data.CNR.it